Flindt相关文献与解析，生知库 | 链接生命科学的每一步

Optimizing seagrass planting arrangements for animal benefits in a multihabitat restoration seascape

在多栖息地修复海景中优化海草种植方案，以造福动物

Sievers, Michael; Brown, Christopher J; Rasmussen, Jasmine A; Nielsen, Benjamin; Steinfurth, Rune C; Flindt, Mogens R; Banke, Timi L; Gilby, Ben L; Connolly, Rod M

发表日期：2025

文献求助收藏

Impacts of Sea Level Rise on Danish Coastal Wetlands - a GIS-based Analysis

海平面上升对丹麦沿海湿地的影响——基于地理信息系统的分析

期刊:Environmental Management

影响因子:3

doi:10.1007/s00267-024-02096-9

Canal-Vergés, Paula; Frederiksen, Lars; Egemose, Sara; Ebbensgaard, Torben; Laustsen, Kristian; Flindt, Mogens R

发表日期：2025

文献求助收藏

Proctocolitis or TikTok-olitis: The dangers of social media influence on home constipation management

直肠结肠炎还是TikTok炎：社交媒体对家庭便秘管理的影响及其危害

期刊:Journal of Pediatric Gastroenterology and Nutrition

影响因子:2.6

doi:10.1002/jpn3.70027

Polachek, Ashley; Flindt, Grant; Lazar, Lauren; Barlow, Sarah

Dementia Dialogue: An Educational Workshop for Medical Students

痴呆症对话：面向医学生的教育研讨会

期刊:

影响因子:

doi:10.1111/jgs.70096

Murphy, Kayla S; Flindt, Grant; Nguyen, Michelle; Freeland, Deborah

发表日期：2025

文献求助收藏

Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801]

对“NNC9204-1177（一种胰高血糖素/GLP-1 受体共激动剂）的三项 1 期试验结果：对超重或肥胖成年人的减肥效果和安全性”的更正 [Mol Metab 78 (2023) 101801]

期刊:Molecular Metabolism

影响因子:6.6

doi:10.1016/j.molmet.2024.102023

Friedrichsen, Martin Haljeta; Endahl, Lars; Kreiner, Frederik Flindt; Goldwater, Ronald; Kankam, Martin; Toubro, Søren; Nygård, Sune Boris

Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial

自主减少饮食钠摄入量对原发性高血压患者血压的影响：一项随机临床试验

期刊:Journal of the American Heart Association

影响因子:5.3

doi:10.1161/JAHA.124.034632

Duus, Camilla Lundgreen; Nielsen, Steffen Flindt; Hornstrup, Bodil Gade; Mose, Frank Holden; Bech, Jesper Nørgaard

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

恩格列净对伴有或不伴有慢性肾病的 2 型糖尿病患者以及非糖尿病慢性肾病患者的影响：3 项交叉随机对照试验方案（SiRENA 项目）

期刊:JMIR Research Protocols

影响因子:1.5

doi:10.2196/56067

Nielsen, Steffen Flindt; Duus, Camilla Lundgreen; Buus, Niels Henrik; Bech, Jesper Nørgaard; Mose, Frank Holden

Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials

胰高血糖素样肽-1受体激动剂延长健康寿命：现状与未来潜力

期刊:Aging Cell

影响因子:7.1

doi:10.1111/acel.13818

Kreiner, Frederik Flindt; von Scholten, Bernt Johan; Kurtzhals, Peter; Gough, Stephen Charles Langford

信号转导

发表日期：2023

文献求助收藏

Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin

恩格列净对肾脏和全身血流动力学影响的随机、安慰剂对照试验

Empagliflozin and fluid balance: results from the SiRENA project

恩格列净与体液平衡：SiRENA 项目的结果

Optimizing seagrass planting arrangements for animal benefits in a multihabitat restoration seascape

在多栖息地修复海景中优化海草种植方案，以造福动物

Impacts of Sea Level Rise on Danish Coastal Wetlands - a GIS-based Analysis

海平面上升对丹麦沿海湿地的影响——基于地理信息系统的分析

Proctocolitis or TikTok-olitis: The dangers of social media influence on home constipation management

直肠结肠炎还是TikTok炎：社交媒体对家庭便秘管理的影响及其危害

Dementia Dialogue: An Educational Workshop for Medical Students

痴呆症对话：面向医学生的教育研讨会

Corrigendum to "Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity" [Mol Metab 78 (2023) 101801]

对“NNC9204-1177（一种胰高血糖素/GLP-1 受体共激动剂）的三项 1 期试验结果：对超重或肥胖成年人的减肥效果和安全性”的更正 [Mol Metab 78 (2023) 101801]

Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial

自主减少饮食钠摄入量对原发性高血压患者血压的影响：一项随机临床试验

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project)

恩格列净对伴有或不伴有慢性肾病的 2 型糖尿病患者以及非糖尿病慢性肾病患者的影响：3 项交叉随机对照试验方案（SiRENA 项目）

Glucagon-like peptide-1 receptor agonists to expand the healthy lifespan: Current and future potentials

胰高血糖素样肽-1受体激动剂延长健康寿命：现状与未来潜力